Your browser doesn't support javascript.
Telemetric Continuous Glucose Monitoring During the COVID-19 Pandemic in Isolated Hospitalized Patients in Denmark: A Randomized Controlled Exploratory Trial.
Klarskov, Carina Kirstine; Windum, Nicole Avlund; Olsen, Mikkel Thor; Dungu, Arnold Matovu; Jensen, Andreas Kryger; Lindegaard, Birgitte; Pedersen-Bjergaard, Ulrik; Kristensen, Peter Lommer.
  • Klarskov CK; Department of Endocrinology and Nephrology, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
  • Windum NA; Department of Endocrinology and Nephrology, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
  • Olsen MT; Department of Endocrinology and Nephrology, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
  • Dungu AM; Department of Pulmonary and Infectious Diseases, and Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
  • Jensen AK; Department of Clinical Research, Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
  • Lindegaard B; Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Pedersen-Bjergaard U; Department of Pulmonary and Infectious Diseases, and Copenhagen University Hospital - North Zealand, Hilleroed, Denmark.
  • Kristensen PL; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Diabetes Technol Ther ; 24(2): 102-112, 2022 02.
Article in English | MEDLINE | ID: covidwho-1594896
ABSTRACT

Objective:

To investigate whether telemetric continuous glucose monitoring (CGM) in hospitalized and isolated patients with diabetes mellitus and coronavirus disease 2019 (COVID-19) is associated with better glycemic outcomes and fewer patient health care worker contacts compared to blood glucose monitoring by traditional point-of-care (POC) glucose testing and to investigate the user aspect of implementing a CGM-system in-hospital. Materials and

Methods:

A randomized controlled exploratory trial was performed on hospitalized and isolated patients with diabetes and COVID-19 from May 2020 until February 2021 at Nordsjællands Hospital, Denmark. Participants were randomized to nonblinded telemetric CGM (as the only glucose monitoring method) or traditional POC glucose testing + blinded CGM. The primary endpoint was time in range (TIR) based on CGM data in both groups. A questionnaire about the user aspect of the CGM system was answered by health care personnel (HCP).

Results:

We included 64 participants in the analysis, 31 in the CGM group and 33 in the POC glucose group. TIR median was 46% for the CGM group and 68% for the POC glucose group (P = 0.368). The mean glucose value for the CGM group was 11.1 and 10.8 mmol/L in the POC glucose group (P = 0.372). CGM was associated with fewer POC glucose measurements (P < 0.001). Out of 30 HCPs, 28 preferred telemetric CGM over POC glucose testing.

Conclusion:

Remote glucose monitoring by CGM did not improve glycemic outcomes compared to traditional POC glucose testing, but was associated with fewer patient-personnel contacts, saving time for HCPs performing diabetes-related tasks. Most HCPs preferred CGM. The study is registered at http//www.clinicaltrials.gov (#NCT04430608).
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Europa Language: English Journal: Diabetes Technol Ther Journal subject: Endocrinology / Therapeutics Year: 2022 Document Type: Article Affiliation country: DIA.2021.0291

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 1 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Europa Language: English Journal: Diabetes Technol Ther Journal subject: Endocrinology / Therapeutics Year: 2022 Document Type: Article Affiliation country: DIA.2021.0291